CannaPharmaRx, Inc. (CPMD) stock

CPMDOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 18, 2026Score 2/30

$0.00+0.00 (0.00%)

Close on Oct 16, 2026Market cap $1.36MP/E –Yield –

CannaPharmaRx gross margin

Gross margin is gross profit as a percentage of revenue.

CannaPharmaRx's gross margin for the twelve months ending Jun 30, 2026 was -88.8%. For fiscal 2025 it was -153.1%, against -357.9% the year before.

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	-153.1%	+204.8
FY2024	Dec 31, 2024	-357.9%	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q2 FY2026	Jun 30, 2026	-50.1%	+218.1
Q1 FY2026	Mar 31, 2026	-65.3%	+84.6
Q4 FY2025	Dec 31, 2025	-375.9%	−25.2
Q3 FY2025	Sep 30, 2025	-67.0%	+47.1
Q2 FY2025	Jun 30, 2025	-268.2%	+1424.6
Q1 FY2025	Mar 31, 2025	-149.9%	–
Q4 FY2024	Dec 31, 2024	-350.7%	–
Q3 FY2024	Sep 30, 2024	-114.1%	–
Q1 FY2024	Mar 31, 2024	-1692.8%	–

Parsed from the XBRL in CannaPharmaRx's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Nov 10, 2006
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is CPMD.

Revenue growth24.8% · median 3829.0%

Gross margin-88.8% · median 50.2%

Net margin-666.2% · median -175.2%

Advertisement
300 × 250

See a number that looks wrong?